- Previous Close
0.4480 - Open
0.4480 - Bid 0.4260 x --
- Ask 0.4580 x --
- Day's Range
0.4280 - 0.4740 - 52 Week Range
0.1900 - 1.0500 - Volume
17,065 - Avg. Volume
346,805 - Market Cap (intraday)
20.024M - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
www.staybletherapeutics.seRecent News: STABL.ST
View MorePerformance Overview: STABL.ST
Trailing total returns as of 2/6/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STABL.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STABL.ST
View MoreValuation Measures
Market Cap
19.59M
Enterprise Value
15.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.98
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-52.64%
Return on Equity (ttm)
-97.00%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-20.4M
Diluted EPS (ttm)
-0.2800
Balance Sheet and Cash Flow
Total Cash (mrq)
8.06M
Total Debt/Equity (mrq)
6.96%
Levered Free Cash Flow (ttm)
-13.07M